These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6362435)

  • 21. Modification of myosin isozymes and SR Ca(2+)-pump ATPase of the diabetic rat heart by lipid-lowering interventions.
    Rupp H; Elimban V; Dhalla NS
    Mol Cell Biochem; 1994 Mar; 132(1):69-80. PubMed ID: 8078510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of free fatty acids and dichloroacetate on isolated working diabetic rat heart.
    Nicholl TA; Lopaschuk GD; McNeill JH
    Am J Physiol; 1991 Oct; 261(4 Pt 2):H1053-9. PubMed ID: 1928388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy.
    Trost SU; Belke DD; Bluhm WF; Meyer M; Swanson E; Dillmann WH
    Diabetes; 2002 Apr; 51(4):1166-71. PubMed ID: 11916940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of propionyl-L-carnitine on oscillatory potentials in electroretinogram in streptozotocin-diabetic rats.
    Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Hara T; Fukasawa H; Kakuta H; Sakamoto N
    Eur J Pharmacol; 1996 Sep; 311(2-3):199-206. PubMed ID: 8891600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of propionyl-carnitine on mitochondrial respiration and post-ischaemic cardiac function in the ischaemic underperfused diabetic rat heart.
    Broderick TL; Paulson DJ; Gillis M
    Drugs R D; 2004; 5(4):191-201. PubMed ID: 15230624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of experimental diabetes on sarcoplasmic reticulum function in rat ventricular muscle.
    Bouchard RA; Bose D
    Am J Physiol; 1991 Feb; 260(2 Pt 2):H341-54. PubMed ID: 1996680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular functions of diabetic cardiomyocytes: contractility, rapid-cooling contracture, and ryanodine binding.
    Yu Z; Tibbits GF; McNeill JH
    Am J Physiol; 1994 May; 266(5 Pt 2):H2082-9. PubMed ID: 8203606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular function after chronic insulin treatment in diabetic and normal rats.
    Schaible TF; Malhotra A; Bauman WA; Scheuer J
    J Mol Cell Cardiol; 1983 Jul; 15(7):445-58. PubMed ID: 6225876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo and in vitro intervention with L-carnitine prevents abnormal energy metabolism in isolated diabetic rat heart: chemical and phosphorus-31 NMR evidence.
    Pieper GM; Murray WJ
    Biochem Med Metab Biol; 1987 Aug; 38(1):111-20. PubMed ID: 3663394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A functional and ultrastructural analysis of experimental diabetic rat myocardium. Manifestation of a cardiomyopathy.
    Jackson CV; McGrath GM; Tahiliani AG; Vadlamudi RV; McNeill JH
    Diabetes; 1985 Sep; 34(9):876-83. PubMed ID: 3896897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effect of exercise training on cardiac long-chain acylcarnitine levels in diabetic rats.
    Broderick TL; St-Laurent R; Rousseau-Migneron S; Tancrede G; Nadeau A
    Diabetes Res; 1990 Jun; 14(2):83-6. PubMed ID: 2134218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of chronic alloxan- and streptozotocin-induced diabetes on isolated rat heart performance.
    Vadlamudi RV; Rodgers RL; McNeill JH
    Can J Physiol Pharmacol; 1982 Jul; 60(7):902-11. PubMed ID: 6215114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention and reversal of altered myocardial function in diabetic rats by insulin treatment.
    Tahiliani AG; Vadlamudi RV; McNeill JH
    Can J Physiol Pharmacol; 1983 May; 61(5):516-23. PubMed ID: 6349759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin improves cardiac function in isolated streptozotocin-diabetic rat hearts.
    Verma S; McNeill JH
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H714-9. PubMed ID: 8141372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of gliclazide on the functional response to calcium in diabetic rat heart.
    Shinzato T; Shimabukuro M; Higa S; Nagamine F; Murakami K; Takasu N
    Gen Pharmacol; 1996 Apr; 27(3):471-5. PubMed ID: 8723529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased cardiac sarcoplasmic reticulum Ca2+ -ATPase activity contributes to cardiac dysfunction in streptozotocin-induced diabetic rats.
    Zhao XY; Hu SJ; Li J; Mou Y; Chen BP; Xia Q
    J Physiol Biochem; 2006 Mar; 62(1):1-8. PubMed ID: 16909926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo antidiabetic actions of naglivan, an organic vanadyl compound in streptozotocin-induced diabetes.
    Cam MC; Cros GH; Serrano JJ; Lazaro R; McNeill JH
    Diabetes Res Clin Pract; 1993 May; 20(2):111-21. PubMed ID: 8375263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATP production and TCA activity are stimulated by propionyl-L-carnitine in the diabetic rat heart.
    Broderick TL
    Drugs R D; 2008; 9(2):83-91. PubMed ID: 18298127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac membrane Ca(2+)-transport in alloxan-induced diabetes in rats.
    Golfman LS; Takeda N; Dhalla NS
    Diabetes Res Clin Pract; 1996 Jul; 31 Suppl():S73-7. PubMed ID: 8864644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of cardiac microsomal sarcoplasmic reticulum prepared from control and diabetic rats.
    Lopaschuk GD; Katz S; McNeill JH
    J Pharmacol Methods; 1983 Nov; 10(3):199-206. PubMed ID: 6228695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.